LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

Search

CONMED Corp

Fermé

SecteurSoins de santé

55.81 5.34

Résumé

Variation du prix de l'action

24h

Actuel

Min

52.4

Max

56.01

Chiffres clés

By Trading Economics

Revenu

15M

21M

Ventes

21M

342M

P/E

Moyenne du Secteur

14.997

35.473

BPA

0.95

Rendement du dividende

1.51

Marge bénéficiaire

6.257

Employés

3,900

EBITDA

4M

38M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+21.84% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.51%

2.38%

Prochains Résultats

29 oct. 2025

Date du Prochain Dividende

3 oct. 2025

Date du Prochain Détachement de Dividende

15 sept. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

76M

1.7B

Ouverture précédente

50.47

Clôture précédente

55.81

Sentiment de l'Actualité

By Acuity

18%

82%

33 / 372 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

CONMED Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 août 2025, 23:09 UTC

Acquisitions, Fusions, Rachats

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

22 août 2025, 22:02 UTC

Acquisitions, Fusions, Rachats

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

22 août 2025, 22:02 UTC

Acquisitions, Fusions, Rachats

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

22 août 2025, 22:02 UTC

Acquisitions, Fusions, Rachats

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

22 août 2025, 22:02 UTC

Acquisitions, Fusions, Rachats

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

22 août 2025, 22:02 UTC

Acquisitions, Fusions, Rachats

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

22 août 2025, 21:23 UTC

Market Talk

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

22 août 2025, 21:18 UTC

Market Talk

US Economic Growth Seen Slowing This Year -- Market Talk

22 août 2025, 21:18 UTC

Acquisitions, Fusions, Rachats

U.S. Takes 10% Stake in Intel -- Barrons.com

22 août 2025, 21:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 août 2025, 21:03 UTC

Market Talk

Mexican Stocks Close At Record High -- Market Talk

22 août 2025, 20:58 UTC

Market Talk

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

22 août 2025, 20:57 UTC

Acquisitions, Fusions, Rachats

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

22 août 2025, 20:57 UTC

Acquisitions, Fusions, Rachats

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

22 août 2025, 20:57 UTC

Acquisitions, Fusions, Rachats

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

22 août 2025, 20:57 UTC

Acquisitions, Fusions, Rachats

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

22 août 2025, 20:57 UTC

Acquisitions, Fusions, Rachats

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

22 août 2025, 20:57 UTC

Acquisitions, Fusions, Rachats

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

22 août 2025, 20:56 UTC

Résultats

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 août 2025, 20:55 UTC

Résultats

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 août 2025, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

22 août 2025, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

22 août 2025, 20:41 UTC

Acquisitions, Fusions, Rachats

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

22 août 2025, 20:24 UTC

Acquisitions, Fusions, Rachats

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

22 août 2025, 20:16 UTC

Acquisitions, Fusions, Rachats

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

22 août 2025, 19:19 UTC

Market Talk

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

22 août 2025, 19:10 UTC

Market Talk

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

22 août 2025, 19:06 UTC

Market Talk

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

22 août 2025, 19:03 UTC

Market Talk

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

22 août 2025, 18:52 UTC

Acquisitions, Fusions, Rachats

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Comparaison

Variation de prix

CONMED Corp prévision

Objectif de Prix

By TipRanks

21.84% hausse

Prévisions sur 12 Mois

Moyen 68 USD  21.84%

Haut 68 USD

Bas 68 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

1

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

51 / 58.13Support & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Strong Bearish Evidence

Sentiment

By Acuity

33 / 372Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos CONMED Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.